✦ LIBER ✦

Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study

✍ Scribed by Sandborn, William J.; Schreiber, Stefan; Hanauer, Stephen B.; Colombel, Jean–Frédéric; Bloomfield, Ralph; Lichtenstein, Gary R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S1035 Certolizumab Pegol is Effective at

✍ Stefan Schreiber; Ian C. Lawrance; Ole O. Thomsen; Stephen B. Hanauer; Ralph Blo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Mo1218 Long-Term Outcomes of Certolizuma

✍ Sandborn, William; Lee, Scott D.; Randall, Charles W.; Gutierrez, Alexandra; Sch 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 505 KB

P021 SUBCUTANEOUS CERTOLIZUMAB PEGOL IS

✍ S. Schreiber; B.G. Feagan; S.B. Hanauer; P. Rutgeerts; W.J. Sandborn 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 59 KB

44 Patients With Crohn's Disease Treated

✍ William J. Sandborn; Stefan Schreiber; Stephen B. Hanauer; Jean-Frederic Colombe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

P022 PATIENTS WITH CROHN'S DISEASE REPOR

✍ B. Feagan; G. Coteur; D. Keininger; S. Schreiber 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 82 KB

S1030 Predictors of Response and Remissi

✍ William J. Sandborn; Maria T. Abreu; Geert R. D'Haens; Jean-Frederic Colombel; S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 142 KB